Experts
Stories by Tim Boreham
Experts
Dr Boreham’s Crucible: Excessive sweater? Botanix is here to get you fit for public consumption again
Experts
CRITERION: At Stawell, gold is the gift that keeps on giving
Experts
CRITERION: Can these fast food stocks supersize profits as competition mounts?
Experts
Dr Boreham’s Crucible: Can the magic acronyms ‘AI’ and ‘FDA’ see Optiscan probe new heights in 2024?
Experts
CRITERION: Looking for retail therapy this festive season? Remember, cheap isn’t always cheerful
Experts
CRITERION: It’s a pool party as private equity splashes cash on small cap financial advisors
Experts
Dr Boreham’s Crucible: Nanosonics is testing more patience than ever. Is it a case of ‘relax and it won’t hurt a bit’?
Experts
CRITERION: Need a cheap vacation from regular ASX losing stocks? There’s a ticker for that
Experts
CRITERION: Paradigm’s set for a proper knees-up if its arthritis fighter is the real deal
Experts
Dr Boreham’s Crucible: Investors have been holding their breath for Pharmaxis’ rebirth. Time to exhale?
Experts